HIV
latest news & developmentsAids is no longer exceptional. What happens now?
The International Aids Conference in Rio de Janeiro highlighted a stark reality: the era of Aids exceptionalism is ending amid unprecedented funding cuts. As science delivers…
What HIV got right — but obesity still hasn’t
As the 26th International Aids Conference convenes, this article draws parallels between the HIV response and the emerging obesity crisis in South Africa. It highlights how…
Could the NHI fuel anti-immigrant sentiment?
Amid rising anti-immigrant sentiment and violence in South Africa, a clause in the National Health Insurance (NHI) Act threatens to deny HIV treatment to refugees, asylum…
Supporting adolescent girls advances us all this International Women’s Day
One in every five girls across sub-Saharan Africa has experienced rape or sexual assault before turning 18
Superbugs plus climate change equals double trouble. Here’s why
As the Earth becomes hotter, we’re seeing more floods and droughts. Flooding can make superbugs spread faster and further. And heat helps germs adapt faster
Decriminalization – a prerequisite to ending Aids and TB
The same structural failures that sustain the HIV epidemic also sustain tuberculosis
HIV made him expect to die at 40. At 73, Edwin Cameron asks: Who’s planning for our ageing survivors?
At 33, the retired Constitutional Court justice thought he had, maybe, seven years left. His story traces the arc from certain death because of Aids to a chronic, manageable…
Cabo Delgado: The Mozambican people forgotten by time
Eight years of violence and displacement but the lives of the people here do not make headlines
SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch
None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab
Building toilets, fighting TB: Candice Andisiwe Sehoma’s life of activism
From discontinued insulin pens to overpriced TB drugs, meet the young South African holding drug makers to account on behalf of patients
The six-monthly anti-HIV jab could be in 360 clinics by February. Who should get the first doses?
The country’s medicines regulator Sahpra says it’s on track to announce its registration decision by the end of October
Clinics short-staffed after Pepfar funding cuts
According to a survey, 85% of managers reported that their clinics faced staffing shortages, though only one in five blamed these on the US President’s Emergency Plan For Aids…
The six-monthly anti-HIV jab is coming. But can SA keep track of millions of users?
The shot, called Lenacapavir, has a 100% success rate in preventing young women from getting HIV through sex
Africa, the cradle of the HIV pandemic, must be the cradle of the cure
The continent has been the testing ground for drugs, devices and diagnostics, many of which never returned in the form of benefit
Dangerous fantasy: US ambassador Dybul said SA was ready to transition off Pepfar. It wasn’t
Weeks later, thousands of health workers are unemployed, HIV services are collapsing and the government hasn’t filled the gap. This isn’t transition, it’s unraveling in real time